The effect of the adapted soccer programme on motor learning and psychosocial behaviour in adolescents with Down syndrome.

BACKGROUND: Numerous studies have proven the significant positive impact of the regular physical activity on general health conditions and quality of life of people with intellectual disability. In practice, various adapted sports activities are used. The current study deals with the effects of the soccer programme. AIM: The purpose of the study is to evaluate the effects of adapted soccer on the motor learning and some psychosocial characteristics in adolescents with Down syndrome. METHODS: Twenty-five participants were recruited and randomised into two groups (exercise and control). Adolescents placed in the exercise group carried out a special soccer programme twice a week during 16 weeks, while adolescents placed in the control group continued with their usual daily regime. Specific motor coordination, level of aggression, attention disorders, level of anxiety and depression, and social problems were measured before and after the training period. Mixed ANOVA were used to evaluate the effects of the experimental treatment. RESULTS: The exercise group had significant improvements (P < 0.05) in one of three motor variables (only in the easiest task) and in all psychosocial variables. There are no one significant change in the control group. The adapted soccer programme influenced more seriously on psychosocial characteristics than on motor learning of adolescent with DS. CONCLUSIONS: The results suggest that adapted soccer training can decrease aggression, anxiety and depression levels, and improve attention, social behaviour and simple motor skills in adolescents with Down syndrome.

The health status of Roma children--a medical or social issue?

BACKGROUND: Most studies dealing with health problems of the Roma population suggests that a low economic status significantly contributes to their overall poor health. In Serbia, Roma people are members of a marginalized ethnic group with a low socioeconomic status which contributes to their much higher morbidity and mortality rate compared with the majority population. The questions we asked in this paper were: Are Roma children discriminated during hospital care? Do they get the same treatment as the non-Roma children? PATIENTS AND METHODS: To answer these questions, we examined medical records of 59 Roma children and compared with 59 records of non-Roma children in order to determine whether there are any differences in the health status, as well as the length, course, outcome, and cost of treatment. RESULTS: Roma children have statistically significant more comorbidity, more malnutritions, more skin diseases (especially parasitic and fungal infections) and were more frequently anemic. Also, the length of hospitalization of Roma children was significantly higher, as well as the number of laboratory tests performed and number of drugs prescribed, which contribute to the significantly higher costs of treatment for Roma children compared to non-Roma children. However, a significantly lower number of Roma children were discharged as "completely cured". CONCLUSIONS: The results of our study does not support hypothesis of discrimination of Roma children concerning medical treatment in observed hospital. At the same time, our results suggests that social interventions (e.g. hygienic housing, water supply, etc.) and prevention measures could prevent necessity of hospitalized treatment of Roma children and could diminish the drain on the health budget spent on treating the consequences of social neglect.

Serum beta-endorphin level in patients with depression on fluvoxamine.

The main interest of the present study was to determine possible alternations in beta-endorphin serum levels in healthy volunteers and in patients with depression, as well as changes in beta-endorphin serum levels caused by fluvoxamine treatment. Fluvoxamine maleate (Fevarin) was administered orally at a dose of 200 mg/day for 4 weeks. The serum levels of beta-endorphin were lower in patients with 'nonendogenous' depression (104.68 +/- 5.29 pg/ml) and those with 'endogenous' depression (36.34 +/- 2.23 pg/ml) than in healthy volunteers (125.19 +/- 1.64 pg/ml). The endogenously depressed patients had significantly lower beta-endorphin levels than the nonendogenous patients. A 4-week treatment of fluvoxamine (200 mg/day) caused a statistically significant increase in beta-endorphin serum levels in all patients (nonendogenous depression 132.10 +/- 2.38 pg/ml and endogenous depression 50.09 +/- 2.45 pg/ml) in comparison to values found before the onset of the therapy. The efficacy of fluvoxamine was 11.0 (+/- 9.0) evaluated by the Hamilton Rating Scale for Depression (HAMD) in the patients with a diagnosis of depression. These results indicate that determination of beta-endorphin serum levels could be a valuable laboratory test in the diagnosis of depression.